HemaSphere
(Jun 2022)
PB1760: AZACITIDINE AS TREATMENT OF KMT2A INFANT ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE
- G. Giagnuolo,
- A. De Matteo,
- P. Stellato,
- F. Petruzziello,
- R. Cuccurullo,
- G. Beneduce,
- F. Cacace,
- F. P. Tambaro,
- R. Parasole,
- G. Menna
Affiliations
- G. Giagnuolo
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- A. De Matteo
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- P. Stellato
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- F. Petruzziello
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- R. Cuccurullo
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- G. Beneduce
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- F. Cacace
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- F. P. Tambaro
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- R. Parasole
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- G. Menna
- 1 Department of Oncology, AORN Santobono-Pausilipon, Napoli, Italy
- DOI
-
https://doi.org/10.1097/01.HS9.0000849896.85988.6c
- Journal volume & issue
-
Vol. 6
pp.
1641
– 1642
WeChat QR code